TYPE 1 DIABETES MELLITUS

Disease Description

Type 1 diabetes mellitus is a medical condition that occurs when the pancreas, an organ in the abdomen, produces very little or no insulin. Insulin, a hormone that helps the body to absorb and use glucose (sugar). Without insulin, blood glucose levels become higher than normal.

Type 1 diabetes mos often develops when the immune system destroys the insulin-producing cells (beta-cells) in the pancreas. This is called an autoimmune response. The cause of this abnormal immune response is still not completely understood.

This process can take time to occur, and initially there may be no symptoms of diabetes. High blood sugar and its associated symptoms (frequent urination, thirst) do not usually occur until more than 90 percent of the cells that make insulin have been destroyed. . Type 1 diabetes usually begins in childhood or young adulthood, but can develop at any age.

Type 1 diabetes can develop in people with a family history of type 1 diabetes, but it also develops in people with no family history of diabetes. In either case, people who develop diabetes have one or more genes that make them susceptible to the disease. Environmental factors, such as exposure to certain viruses and foods early in life, might trigger the autoimmune response. [1]

Prevalence

In 2012, 29.1 million Americans, or 9.3% of the population, had diabetes. Diabetes remains the 7th leading cause of death in the United States in 2010. In the United States, Canada, and Europe, type 1 diabetes accounts for 5 to 10 percent of all cases of diabetes [1]

Current Treatment Options

Insulin treatment is one component of a diabetes treatment plan for people with type 1 diabetes. Insulin treatment replaces the body's own insulin, and aims to restore normal or near-normal blood sugar levels. With a little extra planning, people with diabetes who take insulin can lead a full life and keep their blood sugar under control.[1]

Evidence for and Proposed Mechanism for Cannabinoid Therapies

It was found that CBD treatment of 6- to 12-week-old mice significantly reduces the incidence of diabetes from 86% in nontreated control mice to 30% in CBD-treated mice. Results indicated that CBD can inhibit and delay destructive insulitis and inflammatory Th1-associated cytokine production in mice, resulting in a decreased incidence of diabetes possibly through an immunomodulatory mechanism shifting the immune response.[2] Research strengthens the previous assumption that CBD, known to be safe in humans, can possibly be used as a therapeutic agent for treatment of type 1 diabetes.[2]

1. UpToDate online resource

2. Weiss L, Zeira M, Reich S et al (2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 39:143–151
Category
Critical Ailments
Created
Thursday, 16 March 2017
Group admin
CBIS

1- Million Strong Killing Cancers Foundation & Fight Club!

We are LIVE !!! Join the FIGHT NOW! with Harvard Award Winning,
Low-Cost Cancer-Killing Treatments! Click the Above Image link to setup your Account and begin your Crypto Journey with us. The 1-Million Strong Killing Cancers Foundation, the 1-Million Strong Fight Club, & CSi Labs are making cancer treatments affordable and accessible for millions of patients through our innovative cancer killing fundraising meme token. All Crypto MEME Coin Purchases will be included in the Up and Coming Contests and Promotions!
The Time is Now. 1-Million Strong Killing Cancers!

Click the Below Image to Review our Cancer Drug Comparables
*** Warning this document contains graphic images.

CSi-VIP Awards & NASDAQ Updates
Please Click the Below Image:

1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:

*** Please click image below.

2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:

*** Please click image below.

*** PLUS

(3) other Cannabis Science
REAL WORLD Successes:

Stage 4 Breast Cancer

Skin Cancer

Karposis Sarcoma

The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.

Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.

We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.

Click here to review the Report:

Case No. 2:17-CV-02271-KJM-JDP

Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB

Photos

Observational Studies

CSi-VIP & CBIS-Shareholder Legacy

Please Click the Below Calendar image to book your time to speak with Mr. Dabney about Your CSi-VIP Shareholder Legacy & 1-Million Strong Membership.

One LAST TIME … for CLARITY …

CBIS Original Shareholders - CBIS First Rights, CSi-VIP Bonus Shares, CBIS GIFT Shares, CSi-VIP Drug Ownership Program ...

*** CSi-VIP AWARDS Program !!!

MAKE SURE … You have Your CSi-VIP Membership!

Click the Above image: February 4, 2026, Cannabis Science Inc., Shareholder Close-out. All Cannabis Science Shareholders Qualify.

Above ANNOUNCEMENT: December 31, 2025, Cannabis Science Inc., Shareholder Close-out.

Cannabis Science Financials & FINAL CBIS/CSi-VIP Share Numbers. Click the above Image link to view the latest Report.
November 5, 2025

Cannabis Science Shareholder FINAL Audit Confirmations
Click the above Image link to view the latest Report
September 23, 2025

Cannabis Science Shareholder Audit Confirmations Underway now!
Click the above Image link to view the latest Report.
July 7, 2025

Click the above Image link to view the latest cancer Killing promotional video. This is where you can join our 1-Million Strong youtube page to view more videos as we proceed forward.

June 1, 2025, Pre-Launch Success
Click the above Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time offer!

Click the ABOVE Image to Review our 1-Million Strong FC, Media Kit

*** Warning this document contains exciting images.

Click the above Image to become one of the First 1-Million Strong Killing Cancers, Fight Club Members to help 'Make that Change' Join in Now! * Warning this Membership contains Exciting Results.

PS ...** ALL of our CSi-VIP's and those who Donated through the ASU/CSi-EDP GO-Fund-Me Promotion you do not need to purchase anything, you are ALREADY included in the "First" 1-Million Membership Club, CONGRATULATIONS !!!

Cannabis Science CEO, Presents …

The FINAL “CBIS GIFT Shares” Issuances!

DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!

ALL GIFT Shares 1, 2, & 3 being ISSUED !!!

LAST Steps:

Please confirm Yours NOW !!!

1. CONFIRM Correct Total Share Amount(s)

2. CONFIRM Correct Name(s) on CERTIFICATE

3. CONFIRM Correct Mailing Address

*** giftshares@icannabinoid.com

ASU/CSi-EDP-ECO-System
At it's FINEST !!!

WHICH ONE ARE YOU ??

Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???

We can make this HAPPEN way FASTER Working as a TEAM !!!

WHAT Matters is how much you CARE about KILLING CANCERS ...

This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.

2025 Audit considerations NASDAQ.

Cannabis Science Inc.
Share Structure 2025

Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.

Common Stock:
Authorized:
5,000,000,000

Issued:
2,839,095,296

Fully Diluted:
4,510,547,648

Class A Common Stock
Authorized:
100,000,000

Issued:
0

Class B Common Stock
Authorized:
1,500,000,000

Issued:
0

Preferred Stock
Authorized:
1,000,000

Issued:
1,000,000

Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.

You already know our Extensive LIST of GROUNDBREAKING Products.

1-Million STRONG TV Coverage, HARVARD Award Success.

TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE

*** APPLY for FREE in CONFIDENCE and Success.

Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.

EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!

Activity Stream

RAYMOND, PLEASE RESPOND TO MY EMAIL!   ...Francis G. Cormier III

In 2021, a share exchange was initiated through Thermic Science International Corporation, which acquired Cannabis Science Inc and created new share classes for former shareholders. This transaction effectively transitioned Cannabis Science into a private entity under the Thermic Science umbrella, with the stock trading.

Cannabis Science Inc (formerly CBIS) is delisted and no longer publicly traded, with its shares effectively cancelled following SEC actions.

Delisting and SEC Actions
Cannabis Science Inc was delisted by the SEC due to delinquent filings and failure to meet reporting requirements, after a period of suspension and administrative placement on the Grey Market. The company’s shares were cancelled, and there is no active public trading under its former ticker CBIS (Cannabis Science Inc). The delisting followed regulatory sanctions imposed in October 2019, when the company failed to file timely financial reports, leading to its privatization.

Privatization and Share Exchange
After going private, Cannabis Science ceased issuing quarterly results or investor communications, leaving former shareholders without liquidity. In 2021, a share exchange was initiated through Thermic Science International Corporation, which acquired Cannabis Science Inc and created new share classes for former shareholders. This transaction effectively transitioned Cannabis Science into a private entity under the Thermic Science umbrella, with the stock trading symbol ENDO for the new entity

Current Status
As of 2026, Cannabis Science Inc operates as a private company focused on medical marijuana research and development, including phytocannabinoid-based pharmaceutical products. The company is headquartered in Irvine, California, and has a small team of employees. It continues to engage in research, joint ventures, and corporate development, but its former public shares are no longer active or tradable

Key Takeaways
Cannabis Science Inc is permanently delisted and no longer publicly traded 
SEC sanctions and failure to file financial reports were the primary reasons for delisting
Former shareholders may participate in the Thermic Science share exchange, but the original CBIS shares are cancelled.
The company now operates privately, focusing on cannabinoid-based pharmaceutical research.
Investors should note that there is no public market liquidity for the original Cannabis Science shares, and any potential investment would involve the private entity under Thermic Science International Corporation.

RAYMOND, PLEASE RESPOND TO MY EMAIL! ...Francis G. Cormier III

In 2021, a share exchange was initiated through Thermic Science International... Show more